 |
Articles: Drug/Product Approvals |
Prior Articles
Bristol-Myers Squibb Submits Applications in U.S. and Europe to Market Entecavir, an Investigational Antiviral Treatment For Chronic Hepatitis B Infection
Bristol Myers-Squibb Company, 03/27/09
Free full text
Physio-Control Receives FDA 510(K) Clearance For LIFEPAK 15 Monitor/Defibrillator
Medtronic, 03/27/09
Free full text
Lilly's Zyprexa/Prozac Combo Approved for Depression
PharmExec, 03/26/09 Allos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 03/26/09
Free full text
Covidien Receives FDA Clearance for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter with OxiMax SPD(TM) Alert
Covidien, 03/24/09 Teva Announces Approval and Launch of Geveric Solodyn Extended-Release Tablets
Teva Pharmaceutical Industries, 03/23/09
Free full text
Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
Forest Laboratories, 03/23/09
Free full text
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Genzyme, 03/20/09
Free full text
Glivec recommended for use in Europe as first post-surgery treatment for gastrointestinal stromal tumors
Novartis, 03/20/09
Free full text
Febuxostat for hyperuricemia in patients with gout
American Pharmacists Association, 03/18/09
Free full text
A Critical Appraisal of the Safety and Efficacy of Drug-Eluting Stents
Clinical Pharmacology & Therapeutics, 03/17/09 New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability
Watson Pharmaceuticals, 03/17/09
Free full text
XenoPort to Receive $23 Million in Milestone Payments Associated With FDA Acceptance of Solzira NDA
XenoPort, 03/17/09 FDA Approved First DNA Test for Two Types of Human Papillomavirus
FDA Press Releases, 03/16/09
Free full text
Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
Mylan, 03/13/09 Wyeth V. Levine: An Attorneys Perspective
PharmExec, 03/12/09 FDA Approves Cardiac Adhesion Barrier for Pediatric Use
FDA Press Releases, 03/09/09
Free full text
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
Forest Laboratories, 03/09/09
Free full text
Acanya? gel, a new treatment for moderate to severe acne, launched by coria laboratories
Valeant Pharmaceuticals International, 03/09/09
Free full text
Synthon announces European approvals for generic Montelukast February 2009
Synthon, 03/06/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
